Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
12. März 2024 07:30 ET
|
Bioventus, Inc.
Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
04. März 2024 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
18. Januar 2024 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered...
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
12. Januar 2024 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on...
Bioventus Names Robert Claypoole as President and Chief Executive Officer
19. Dezember 2023 16:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of...
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
06. Dezember 2023 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract...
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
07. November 2023 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
31. Oktober 2023 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus to Present at the Cantor Global Healthcare Conference
19. September 2023 21:52 ET
|
Bioventus, Inc.
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
06. September 2023 16:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Tony Bihl, interim chief executive officer,...